Enlivex Therapeutics Ltd.

Nasdaq ENLV · Tel Aviv, Israel

Works in Dermatology · GI & liver · Infectious disease · Musculoskeletal · Renal & urogenital · Respiratory · Women's health

Enlivex Therapeutics Ltd. is a clinical trial sponsor based in Tel Aviv, Israel, listed as Nasdaq ENLV. It has 1 active clinical trial with 182 planned participants, across 7 therapeutic areas. Since 2021 it has completed 2 trials and stopped 2 early.

Trial track record · since 2021

1Active trials182 planned participants
2Completed0 with results posted
2Stopped earlyterminated, withdrawn or suspended

Financials · Nasdaq ENLV

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 1 active trial

StageTrialStatus

Questions about Enlivex Therapeutics Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-04.

Approve Suite is not affiliated with Enlivex Therapeutics Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.